AI-generated summary
The authors retrospectively reviewed 116 patients with café-au-lait macules treated with picosecond or nanosecond 1064-nm Nd:YAG lasers between 2020 and 2022. They report no statistically significant difference in lesion clearance between the two lasers, with the picosecond group showing numerically fewer complications. Because the study was retrospective and efficacy was judged from photographs, the findings should be interpreted cautiously.
- Participants
- 116
- Who or what was studied
- Patients with café-au-lait macules treated with picosecond (83) or nanosecond (33) 1064-nm Nd:YAG laser
- Wavelengths
- 1064 nm
- Limits stated in the abstract
- The retrospective design and photograph-based efficacy assessment are limitations, and the abstract reports no statistically significant efficacy difference and no significant difference in complications or relapse between groups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.